Recombinant Human EGF

Recombinant Human EGF 

To Order Contact us: lieven@wlsolutions.be

Recombinant Human EGF, 1-51a.a.

HEGFP-0502 100ug Ask for price

Recombinant Human EGF Protein

RP01556 500μg
EUR 65

Recombinant Human EGF Protein

RP01556LQ 50μg
EUR 26

Recombinant Human EGF Protein

RP01030 20 μg
EUR 151.2

Recombinant Human EGF Protein

E40KMP1945 20ug
EUR 495

Recombinant Human HB-EGF (Heparin Binding EGF)

Z102155 50 µg
EUR 85
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans.

Recombinant Human HB-EGF (Heparin Binding EGF)

Z102157 200 µg
EUR 240
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans.

Recombinant Human HB-EGF (Heparin Binding EGF)

Z102159 1.0 mg
EUR 750
Description: Human HBEGF (Heparin Binding EGF like growth factor) is a member of the EGF family of peptide growth factors that signal through the EGF receptor, and stimulates the proliferation of smooth muscle cells, fibroblasts, epithelial cells, and keratinocytes. HBEGF is expressed in many cell types and tissues, including bronchial epithelium, visceral and vascular smooth muscle, CD4+ T cells, glomerular podocytes, keratinocytes, macrophages and certain tumor cells. Mature HBEGF is a soluble peptide that arises from the proteolytic processing of the 208 amino acid type-I transmembrane form and exhibits the ability to specifically bind heparin and heparin sulfate proteoglycans.

EGF Receptor, human recombinant

7135-10 each
EUR 280.8

EGF Receptor, human recombinant

7135-50 each
EUR 1032

Recombinant Human EGF-L7 Protein

PROTQ9UHF1 10ug
EUR 380.4
Description: EGF-L7 (Epidermal Growth Factor Like Protein 7, Multiple EGF Like Domains Protein 7, VE Statin) is a multi-domain protein containing two EGF like domains and one EMI domain. It is expressed almost exclusively in endothelial cells and functions to promote normal development of the vascular system, particularly tubulogenesis. EGF-L7 is capable of antagonistic binding to Notch receptors resulting in the inhibition of Notch signaling in HUVEC and neural stem cells. In research models inducing hypoxia and subsequent reoxygenation, (H/R), EGF-L7 can inhibit ICAM-1 expression and enhance the inhibition of NF-kappaB activation. Additionally, EGF-L7 can chemoattract endothelial cells and bind to the extracellular matrix. The overexpression of EGF-L7 is observed in various cancers, and is generally correlated with increased metastasis and a poor prognosis.  Recombinant human EGF-L7 is a 28 kDa protein containing 251 amino acid residues.

Human CellExp? EGF, human recombinant

7228-10 each
EUR 352.8

Active Recombinant Human EGF Protein

RP01502 10μg
EUR 104

Recombinant Human EGF Receptor (EGFR) Protein

PROTP00533-3 10ug
EUR 380.4
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGFα, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions.

Recombinant Human EGF Protein, No Tag

E40KMH1011 20ug
EUR 495

Recombinant Human EGF Protein, His Tag

E40KMH566 20ug
EUR 495

Genorise® recombinant human EGF protein

GR119159 10 µg
EUR 193

Human EGF Recombinant Protein Lyophilized

IHUEGFRLY100UG each
EUR 341
Description: Human EGF Recombinant Protein Lyophilized

Recombinant Human EGF Protein, Fc & His Tag

E40KMP1438 20ug
EUR 495

Recombinant Human Epidermal Growth Factor/EGF

C029-10ug 10ug
EUR 84
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-1mg 1mg
EUR 230.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-500ug 500ug
EUR 178.8
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

C029-50ug 50ug
EUR 120
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0.

Recombinant Human Epidermal Growth Factor/EGF

AP74788 1mg
EUR 329

BD egf human recombinant e Coli 1mg

356052 PK10
EUR 1534.8

Recombinant Human EGF Protein (aa 971-1023) [Fc]

VAng-Cr3970-100g 100 µg
EUR 355.2
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) fused with a Fc tag at N-terminus was expressed in HEK293 Cells, with a molecular weight of 33 kDa. (Accession ID: NP_001954.2)

Recombinant Human EGF Protein (aa 971-1023) [Fc]

VAng-Cr3970-1mg 1 mg
EUR 963.6
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) fused with a Fc tag at N-terminus was expressed in HEK293 Cells, with a molecular weight of 33 kDa. (Accession ID: NP_001954.2)

Recombinant Human HB-EGF

HEGFP-0803 10ug Ask for price

Human EGF-L7 Recombinant Protein Lyophilized

IHUEGFL7RLY10UG each
EUR 317
Description: Human EGF-L7 Recombinant Protein Lyophilized

Human EGF-L7 Recombinant Protein Lyophilized

IHUEGFL7RLY2UG each
EUR 317
Description: Human EGF-L7 Recombinant Protein Lyophilized

Recombinant Human EGF Protein (aa 971-1023) (Yeast)

VAng-Cr3968-100g 100 µg
EUR 355.2
Description: Recombinant Human EGF Protein (Asn971-Arg1023) was expressed in Yeast, with a molecular weight of 6.2 kDa. (Accession ID: NP_001954.2)

Recombinant Human EGF Protein (aa 971-1023) (Yeast)

VAng-Cr3968-1mg 1 mg
EUR 963.6
Description: Recombinant Human EGF Protein (Asn971-Arg1023) was expressed in Yeast, with a molecular weight of 6.2 kDa. (Accession ID: NP_001954.2)

EGF, rat recombinant

4024-100 each
EUR 364.8

EGF, rat recombinant

4024-1000 each
EUR 2173.2

EGF, rat recombinant

4024-20 each
EUR 192

Recombinant Rat EGF

REGFP-0501 100ug Ask for price

Recombinant Rat EGF

Z300045 100 µg
EUR 120
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF receptors are expressed in almost all types of tissues. Parietal endoderm, mature skeletal muscles, and hematopoietic tissues do not express the receptor. The EGF receptor, designated HER1, is a 170 kDa transmembrane glycoprotein with a length of 1186 amino acids. It is identical with a previously described glycoprotein called SA-7 (species antigen 7). The extracellular receptor domain has a length of 621 amino acids, including 11 glycosylated asparagine residues and 51 cysteine residues. This domain contains the EGF binding site and also binds mammalian TGF-alpha.

Recombinant Rat EGF

Z300049 1.0 mg
EUR 480
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF receptors are expressed in almost all types of tissues. Parietal endoderm, mature skeletal muscles, and hematopoietic tissues do not express the receptor. The EGF receptor, designated HER1, is a 170 kDa transmembrane glycoprotein with a length of 1186 amino acids. It is identical with a previously described glycoprotein called SA-7 (species antigen 7). The extracellular receptor domain has a length of 621 amino acids, including 11 glycosylated asparagine residues and 51 cysteine residues. This domain contains the EGF binding site and also binds mammalian TGF-alpha.

Epidermal Growth Factor (EGF), human recombinant

4022-100 each
EUR 176.4

Epidermal Growth Factor (EGF), human recombinant

4022-1000 each
EUR 424.8

Epidermal Growth Factor (EGF), human recombinant

4022-500 each
EUR 320.4

Epidermal Growth Factor (EGF), human recombinant

4022-5000 each
EUR 1358.4

Epidermal Growth Factor (EGF), human recombinant

P1008-.1 100 µg
EUR 193.2
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Epidermal Growth Factor (EGF), human recombinant

P1008-.5 500 µg
EUR 375.6
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Epidermal Growth Factor (EGF), human recombinant

P1008-1 1 mg
EUR 477.6
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Epidermal Growth Factor (EGF), human recombinant

P1008-5 5 mg
EUR 1646.4
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Human EGF receptor Recombinant Protein Lyophilized

IHUEGFRRLY2UG each
EUR 341
Description: Human EGF receptor Recombinant Protein Lyophilized

Recombinant Mouse EGF

Z200025 500 µg
EUR 240
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF receptors are expressed in almost all types of tissues . Parietal endoderm, mature skeletal muscles, and hematopoietic tissues do not express the receptor. The EGF receptor, designated HER1, is a 170 kDa transmembrane glycoprotein with a length of 1186 amino acids. It is identical with a previously described glycoprotein called SA-7 (species antigen 7). The extracellular receptor domain has a length of 621 amino acids, including 11 glycosylated asparagine residues and 51 cysteine residues. This domain contains the EGF binding site and also binds mammalian TGF-alpha.

Recombinant Mouse EGF

Z200029 1.0 mg
EUR 420
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF receptors are expressed in almost all types of tissues . Parietal endoderm, mature skeletal muscles, and hematopoietic tissues do not express the receptor. The EGF receptor, designated HER1, is a 170 kDa transmembrane glycoprotein with a length of 1186 amino acids. It is identical with a previously described glycoprotein called SA-7 (species antigen 7). The extracellular receptor domain has a length of 621 amino acids, including 11 glycosylated asparagine residues and 51 cysteine residues. This domain contains the EGF binding site and also binds mammalian TGF-alpha.

Human CellExp? EGF, Fc Tag, Mouse recombinant

P1428-10 each
EUR 196.8

Human CellExp? EGF, Fc Tag, Mouse recombinant

P1428-50 each
EUR 548.4

Recombinant Human Epidermal Growth Factor (rHu EGF)

AK9797-0100 100µg
EUR 1194

Recombinant Human Epidermal Growth Factor ( rHu EGF )

70504 500ug
EUR 235
Description: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine Balb/c 3T3 cells is less than 0.1 ng/ml, corresponding to a specific activity of > 1.0 × 107 IU/mg.

Recombinant Human Neuregulin 1-alpha EGF Domain

AP60115 100ug
EUR 449

EGF, murine recombinant

4023-100 each
EUR 164.4

EGF, murine recombinant

4023-1000 each
EUR 385.2

EGF, murine recombinant

4023-500 each
EUR 307.2

EGF, murine recombinant

4023-5000 each
EUR 1299.6

Recombinant Murine EGF

MEGFP-0501 100ug Ask for price

EGF Recombinant Protein

11-373 0.1 mg
EUR 651.3
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.

EGF Recombinant Protein

11-495 0.1 mg
EUR 651.3
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.

EGF Recombinant Protein

40-450-01mg 0.1 mg
EUR 311.1
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

40-450-05mg 0.5 mg
EUR 437.1
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

40-477-002mg 0.02 mg
EUR 311.1
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

40-477-01mg 0.1 mg
EUR 437.1
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

40-586-01mg 0.1 mg
EUR 311.1
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

40-586-05mg 0.5 mg
EUR 437.1
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds.

EGF Recombinant Protein

91-020 0.05 mg
EUR 374.1
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF is a small 53 amino acid residue long protein that contains three disulfide bridges

EGF Recombinant Protein

92-245 0.05 mg
EUR 374.1
Description: EGF is a single-pass type I membrane protein,containing 8 LDL-receptor class B repeats and 9 EGF-like domains. EGF results in cellular proliferation, differentiation, and survival.EGF is a low-molecular-weight polypeptide first purified from the mouse submandibular gland, but since then found in many human tissues including submandibular gland, parotid gland. Salivary EGF, which seems also regulated by dietary inorganic iodine, also plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents.

EGF Recombinant Protein

90-455 100 ug
EUR 437.1
Description: Epidermal growth factor (EGF) is a growth factor and the founding member of the EGF family. All EGF family members are synthesized as type I transmembrane precursor proteins that may contain several EGF domains in the extracellular region. The mature proteins are released from the cell surface by regulated proteolysis. EGF is present in various body fluids, including blood, milk, urine, saliva, seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid. Four ErbB (HER) family receptor tyrosine kinases including EGFR/ErbB1, ErbB2, ErbB3 and ErbB4, mediate responses to EGF family members. These receptors undergo a complex pattern of ligand induced homo or heterodimerization to transduce EGF family signals. EGF binds to the receptor EGFR stimulating the intrinsic protein-tyrosine kinase activity of the receptor. The tyrosine kinase activity initiates a signal transduction cascade that results in a variety of biochemical changes within the cell, including a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR, which lead to DNA synthesis, cell growth, proliferation and differentiation. Other biological activities ascribed to EGF include epithelial development, angiogenesis, inhibition of gastric acid secretion, fibroblast proliferation, and colony formation of epidermal cells in culture. Defects in EGF are the cause of hypomagnesemia type 4 (HOMG4), also known as renal hypomagnesemia normocalciuric. HOMG4 is a disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to mederate psychomotor retardation, and brisk tendon reflexes.

HB-EGF, human recombinant

4266-10 each
EUR 164.4

HB-EGF, human recombinant

4266-1000 each
EUR 2408.4

HB-EGF, human recombinant

4266-50 each
EUR 301.2

Recombinant Human EGF Protein (aa 971-1023) (E. coli)

VAng-Cr3965-100g 100 µg
EUR 355.2
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) was expressed in E. coli, with a molecular weight of 6.3 kDa. (Accession ID: NP_001954.2)

Recombinant Human EGF Protein (aa 971-1023) (E. coli)

VAng-Cr3965-1mg 1 mg
EUR 963.6
Description: Recombinant Human EGF Protein (Asn 971-Arg 1023) was expressed in E. coli, with a molecular weight of 6.3 kDa. (Accession ID: NP_001954.2)

Human EGF Recombinant Protein Fc Tag Lyophilized

IHUEGFRFCLY100UG each
EUR 479
Description: Human EGF Recombinant Protein Fc Tag Lyophilized

Human EGF Recombinant Protein Tag Free Lyophilized

IHUEGFRTFLY50UG each
EUR 398
Description: Human EGF Recombinant Protein Tag Free Lyophilized

Epidermal Growth Factor,Human Recombinant(EGF), Pichia

CG016-100 100ug
EUR 351.6

Epidermal Growth Factor,Human Recombinant(EGF), Pichia

CG016-101 1mg
EUR 1340.4

Epidermal Growth Factor,Human Recombinant(EGF), Pichia

CG016-500 500ug
EUR 489.6

Recombinant Human HB-EGF Protein

PROTQ99075-2 50ug
EUR 380.4
Description: HB-EGF is an EGF related growth factor that signals through the EGF receptor, and stimulates the proliferation of smooth muscle cells (SMC), fibroblasts, epithelial cells, and keratinocytes. HB-EGF is expressed in numerous cell types and tissues, including vascular endothelial cells and SMC, macrophages, skeletal muscle, keratinocytes, and certain tumor cells. The ability of HB-EGF to specifically bind heparin and heparin sulfate proteoglycans is distinct from other EGF-like molecules, and may be related to the enhanced mitogenic activity, relative to EGF, that HB-EGF exerts on smooth muscle cells. The human HB-EGF gene encodes a 208 amino acid transmembrane protein, which can be proteolytically cleaved to produce soluble HB-EGF. Recombinant human HB-EGF is a 9.7 kDa protein containing 86 amino acid residues, corresponding to the extra-cellular EGF-like and heparin binding domains of the full length HB-EGF protein.

Recombinant Human HB-EGF Protein

RP00754 20μg
EUR 120.25

Recombinant Human HB-EGF Protein

RP02844 10μg
EUR 299

Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His)

CS13-10ug 10ug
EUR 120
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His)

CS13-1mg 1mg
EUR 1064.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His)

CS13-500ug 500ug
EUR 759.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His)

CS13-50ug 50ug
EUR 199.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His)

AP76388 1mg
EUR 1289

Human EGF R Recombinant Protein Fc Tag Lyophilized

IHUEGFRRFCLY100UG each
EUR 592
Description: Human EGF R Recombinant Protein Fc Tag Lyophilized

Recombinant Human Neuregulin 1-beta2 EGF-like Domain

AP60108 100ug
EUR 449

Recombinant Human EGF Protein, Untagged, Pichia Pastoris-1mg

QP10582-1mg 1mg
EUR 381.6

EGF R Recombinant Protein

11-470 0.1 mg
EUR 884.4
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

EGF R Recombinant Protein

11-547 0.1 mg
EUR 519
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

EGF R Recombinant Protein

11-548 0.1 mg
EUR 714.3
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

EGF R Recombinant Protein

97-062 0.05 mg
EUR 588.3
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

EGF R Recombinant Protein

97-063 0.1 mg
EUR 588.3
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

Recombinant Human EGF (Leu 21) Protein, Untagged, E.coli-1mg

QP10583-1mg 1mg
EUR 1186.8

Recombinant Rat EGF Protein

PROTP07522-2 100ug
EUR 380.4
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds.

Recombinant Human EGF (Leu 21) Protein, Untagged, E.coli-20ug

QP10583-20ug 20ug
EUR 186

Human EGF R Recombinant Protein Strep Tag Lyophilized

IHUEGFRRSTREPLY25UG each
EUR 672
Description: Human EGF R Recombinant Protein Strep Tag Lyophilized

Recombinant Human EGF Protein, Untagged, Pichia Pastoris-100ug

QP10582-100ug 100ug
EUR 186

Recombinant Human EGF Protein, Untagged, Pichia Pastoris-500ug

QP10582-500ug 500ug
EUR 241.2

Recombinant Human Pro-epidermal growth factor(EGF) ,partial

AP71922 1mg
EUR 1978

EGF-L7 Recombinant Protein

40-632 2 ug
EUR 311.1
Description: EGF-L7 (Epidermal growth factor-like protein 7, Multiple EGF-like domains protein 7, VE-statin) is a multi-domain protein containing two EGF-like domains and one EMI domain. It is expressed almost exclusively in endothelial cells and functions to promote normal development of the vascular system, particularly tubulogenesis. EGF-L7 is capable of antagonistic binding to Notch receptors, resulting in the inhibition of Notch signaling in HUVEC and neural stem cells. In research models inducing hypoxia and subsequent reoxygenation (H/R), EGF-L7 can inhibit ICAM-1 expression and enhance the inhibition of NF-κB activation. Additionally, EGF-L7 can chemoattract endothelial cells and bind to the extracellular matrix. The overexpression of EGF-L7 is observed in various cancers, and is generally correlated with increased metastasis and a poor prognosis. Recombinant Human EGF-L7 is a 27.4 kDa protein containing 251 amino acid residues.

EGF-L7 Recombinant Protein

40-633 10 ug
EUR 311.1
Description: Originally identified as a differentiation antigen of mesotheliomas, ovarian cystadenocarcinomas, and pancreatic adenocarcinomas, Mesothelin is a glycosylphosphatidylinositol (GPI)-anchored, cell-surface glycoprotein predominantly secreted by cells of the mesothelium. Although Mesothelin is expressed at restricted levels by normal mesothelial cells of the pleural,pericardial, and peritoneal membranes, aberrant expression has been documented in the aforementioned cancers, as well as in endometriod uterine adenocarcinomas and squamous cell carcinomas of the esophagus, stomach, lung, and cervix. Proteolytic cleavage of Mesothelin yields a soluble, polypeptide fragment designated megakaryocyte potentiating factor (MPF) based on its ability to stimulate megakaryocyte colony-forming activity of murine interleukin-3 in murine bone marrow cell cultures. Originally isolated from the HPC-Y5 pancreatic cell line, MPF has been suggested to play a role in the proliferation and differentiation of megakaryoctyes, and the regulation of resultant platelet production. While the biological functions of both Mesothelin and MPF remain speculative, high-levels of expression in cancerous tissues compared to limited distribution in normal tissues strongly suggests their involvement in tumorigenesis. Both have been demonstrated to promote tumor cell proliferation, migration,anchorage-independent growth, and tumor progression; demonstrating their involvement in heterotypic cell adhesion and the metastatic spread of cancer. CHO cell-derived Recombinant Human MPF is the 250 amino acid-length fragment of the Mesothelin sequence, and has a calculated molecular weight of approximately 26.7 kDa. As a result of glycosylation, Recombinant Human MPF migrates with an apparent molecular mass of approximately 32-33 kDa by SDS-PAGE gel, under reducing and non-reducing conditions.

Recombinant Human EGF (Leu 21) Protein, Untagged, E.coli-100ug

QP10583-100ug 100ug
EUR 241.2

Recombinant Human Heparin-binding EGF-like Growth Factor

AP60083 100ug
EUR 449

Recombinant Human Neuregulin 1-beta1 EGF Domain, 177-241a.a.

AP60109 100ug
EUR 449

Recombinant Mouse EGF Protein

RP01684 20μg
EUR 130

Recombinant Mouse EGF Protein

RP00628 10 μg
EUR 147.6

Recombinant Murine EGF Protein

PROTP01132-4 500ug
EUR 380.4
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds.

EGFL6 EGF Like Domain Multiple 6 Human Recombinant Protein

PROTQ8IUX8 Regular: 500ug
EUR 2085.6
Description: EGF Like Domain Multiple 6 Human Recombinant produced in HEK cells is a polypeptide chain (Asn22-Arg363) containing a total of 348 amino acids (including a 6xHis tag at C-terminus) and having a predicted molecular mass of 40kDa.;The EGFL6 is purified by proprietary chromatographic techniques.

EGF receptor Recombinant Protein

40-516-0002mg 0.002 mg
EUR 311.1
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGF, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions.

EGF receptor Recombinant Protein

40-516-001mg 0.01 mg
EUR 437.1
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGF, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions.

Human EGF R 110-115 kDa Recombinant Protein His Tag Lyophilized

IHUEGFR110115KDARHISLY100UG each
EUR 1069
Description: Human EGF R 110-115 kDa Recombinant Protein His Tag Lyophilized

Human EGF R 95-120 kDa Recombinant Protein His Tag Lyophilized

IHUEGFR95120KDARHISLY100UG each
EUR 851
Description: Human EGF R 95-120 kDa Recombinant Protein His Tag Lyophilized

Recombinant Human EGF